Tales from the Heart

India’s Growing HCM Awareness Movement

Lisa Salberg welcomes Ram Khandelwal and Pallari Kamat for a global conversation about expanding HCM awareness and patient advocacy across India. The episode explores the challenges of diagnosis, healthcare access, and education while highlighting efforts to build stronger support systems for patients and families worldwide.

 

This conversation was recorded May 7, 2026.

SPECIAL REPORT: A Breakthrough for Non Obstructive HCM

Lisa Salberg and Dr. Marty Maron break down major new clinical trial results that could change treatment for patients with non obstructive HCM. They explain what the Acacia HCM trial found, why experts call it a transformative moment, and what the next steps could mean for patients around the world.

 

This conversation was recorded May 5, 2026.

HCM Treatment Shifts and New Therapies

Lisa Salberg and Dr. Matt Martinez break down how medical management for HCM is rapidly evolving, from traditional beta blockers to game-changing myosin inhibitors. They also preview what’s next, including emerging drugs, clinical trials, and new approaches that could reshape care in the near future.

 

This conversation was recorded May 1, 2026

Atrial Fibrillation Risk and New HCM Therapies

Lisa Salberg and Dr. Ethan Rowin break down new data on atrial fibrillation risk in patients taking myosin inhibitors for HCM. They explain what the latest research shows, how risk compares to traditional care, and what patients should watch for as treatment options continue to evolve.

 

This conversation was recorded April 28, 2026.

Understanding HCM Genetics Together

Lisa Salberg is joined by Lynda Neuhausen and Vi Tang to launch a new discussion group focused on the genetics of hypertrophic cardiomyopathy. They explore the science behind genetic testing, the emotional impact on families, and how open conversation can help patients navigate uncertainty and risk together.

 

This conversation was recorded April 24, 2026.

Honoring a Pioneer and HCM Progress

Lisa Salberg and Dr. Steve Ommen reflect on the legacy of a cardiology pioneer who helped shape modern HCM care, while discussing the latest in genetics, diagnosis, and treatment. They break down how far the field has come and what patients should understand as care continues to evolve.

 

This conversation was recorded April 24, 2026

Generic Drug Risks and Patient Safety

Lisa Salberg and Dr. Harry Lever take a hard look at generic drug quality and why consistency matters for people living with HCM. They break down real-world risks, what patients should watch for at the pharmacy, and how policy changes could improve safety nationwide.

 

This conversation was recorded April 17, 2026.

New Trial Targets Symptoms Beyond Obstruction

Lisa Salberg and Dr. Ahmed Masri break down the SONATA HCM clinical trial and a new approach that targets metabolism, not just pressure, in the heart. They explain who may qualify, what to expect, and why patient participation is critical to advancing better treatments for both obstructive and non-obstructive HCM.

 

This conversation was recorded April 14, 2026

New Therapies and What Comes Next

Lisa Salberg and Dr. Marty Maron break down the latest HCM developments from ACC, including emerging myosin inhibitors, AI in imaging, and new approaches to fibrosis and genetic therapies. They also explain what these advances mean for patients now and how to prepare for a rapidly evolving treatment landscape.

 

This conversation was record April 10, 2026

Planning Ahead With HCM: What Matters Most

Lisa Salberg and Dr. Alex de Feria walk through how patients can stay proactive with hypertrophic cardiomyopathy—from annual testing and symptom tracking to understanding when to act. They break down real-world decision making, hidden symptoms, and how evolving care strategies can help patients stay ahead of their condition.

 

This conversation was recorded March 26, 2026.